299 research outputs found
Investigating LGALS3BP/90âK glycoprotein in the cerebrospinal fluid of patients with neurological diseases
© The Author(s) 2020. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the articleâs Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the articleâs Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.Galectin-3 binding protein (LGALS3BP or 90 K) is a secreted glycoprotein found in human body fluids. Deregulated levels were observed in cancer and infection and its study in neurological diseases is more recent. Here, we have investigated 90 K from human cerebrospinal fluid (CSF) of patients with amyotrophic lateral sclerosis (ALS, n = 35) and other neurological diseases (n = 23). CSF was fractionated by ultrafiltration/size-exclusion chromatography (SEC) and eluted fractions were analysed by complementary techniques including immunoblotting, electron microscopy and nano-liquid chromatography-tandem mass spectrometry. A fraction of 90 K appeared as nanoparticles of irregular shape with heterogeneous dimensions of 15-60 nm that co-eluted with extracellular vesicles in SEC. Median levels of 90 K quantified by ELISA were not different between ALS patients (215.8 ng/ml) and controls (213.3 ng/ml) in contrast with the benchmark biomarker for ALS phosphoneurofilament heavy chain (1750 and 345 pg/ml, respectively). A multiregression model supported age is the only independent predictor of 90 K level in both groups (p < 0.05). Significant correlation was found between 90 K levels and age for the ALS group (r = 0.366, p = 0.031) and for all subjects (r = 0.392, p = 0.003). In conclusion, this study unveils the presence of 90 K-containing nanoparticles in human CSF and opens novel perspectives to further investigate 90 K as potential aging marker.This work was supported by Euronanomed 2 ERA-NET project GlioEx (ENMed/0001/2013), Fundação para a CiĂȘncia e a Tecnologia (FCT), Portugal; iNOVA4Health Research Unit (LISBOA-01â0145-FEDER-007344), which is cofunded by FCT/MinistĂ©rio da CiĂȘncia e do Ensino Superior, through national funds; and by FEDER under the PT2020 Partnership Agreement.info:eu-repo/semantics/publishedVersio
Accreditation Standard Guideline Initiative for Tai Chi and Qigong Instructors and Training Institutions.
Evidence of the health and wellbeing benefits of Tai Chi and Qigong (TQ) have emerged in the past two decades, but TQ is underutilized in modern health care in Western countries due to lack of promotion and the availability of professionally qualified TQ instructors. To date, there are no government regulations for TQ instructors or for training institutions in China and Western countries, even though TQ is considered to be a part of Traditional Chinese medicine that has the potential to manage many chronic diseases. Based on an integrative health care approach, the accreditation standard guideline initiative for TQ instructors and training institutions was developed in collaboration with health professionals, integrative medicine academics, Tai Chi and Qigong master instructors and consumers including public safety officers from several countries, such as Australia, Canada, China, Germany, Italy, Korea, Sweden and USA. In this paper, the rationale for organizing the Medical Tai Chi and Qigong Association (MTQA) is discussed and the accreditation standard guideline for TQ instructors and training institutions developed by the committee members of MTQA is presented. The MTQA acknowledges that the proposed guidelines are broad, so that the diversity of TQ instructors and training institutions can be integrated with recognition that these guidelines can be developed with further refinement. Additionally, these guidelines face challenges in understanding the complexity of TQ associated with different principles, philosophies and schools of thought. Nonetheless, these guidelines represent a necessary first step as primary resource to serve and guide health care professionals and consumers, as well as the TQ community
Characterization of Granulations of Calcium and Apatite in Serum as Pleomorphic Mineralo-Protein Complexes and as Precursors of Putative Nanobacteria
Calcium and apatite granulations are demonstrated here to form in both human and
fetal bovine serum in response to the simple addition of either calcium or
phosphate, or a combination of both. These granulations are shown to represent
precipitating complexes of protein and hydroxyapatite (HAP) that display marked
pleomorphism, appearing as round, laminated particles, spindles, and films.
These same complexes can be found in normal untreated serum, albeit at much
lower amounts, and appear to result from the progressive binding of serum
proteins with apatite until reaching saturation, upon which the mineralo-protein
complexes precipitate. Chemically and morphologically, these complexes are
virtually identical to the so-called nanobacteria (NB) implicated in numerous
diseases and considered unusual for their small size, pleomorphism, and the
presence of HAP. Like NB, serum granulations can seed particles upon transfer to
serum-free medium, and their main protein constituents include albumin,
complement components 3 and 4A, fetuin-A, and apolipoproteins A1 and B100, as
well as other calcium and apatite binding proteins found in the serum. However,
these serum mineralo-protein complexes are formed from the direct chemical
binding of inorganic and organic phases, bypassing the need for any biological
processes, including the long cultivation in cell culture conditions deemed
necessary for the demonstration of NB. Thus, these serum granulations may result
from physiologically inherent processes that become amplified with calcium
phosphate loading or when subjected to culturing in medium. They may be viewed
as simple mineralo-protein complexes formed from the deployment of
calcification-inhibitory pathways used by the body to cope with excess calcium
phosphate so as to prevent unwarranted calcification. Rather than representing
novel pathophysiological mechanisms or exotic lifeforms, these results indicate
that the entities described earlier as NB most likely originate from calcium and
apatite binding factors in the serum, presumably calcification inhibitors, that
upon saturation, form seeds for HAP deposition and growth. These calcium
granulations are similar to those found in organisms throughout nature and may
represent the products of more general calcium regulation pathways involved in
the control of calcium storage, retrieval, tissue deposition, and disposal
TSG-6 Regulates Bone Remodeling through Inhibition of Osteoblastogenesis and Osteoclast Activation
TSG-6 is an inflammation-induced protein that is produced at pathological sites, including arthritic joints. In animal models of arthritis, TSG-6 protects against joint damage; this has been attributed to its inhibitory effects on neutrophil migration and plasmin activity. Here we investigated whether TSG-6 can directly influence bone erosion. Our data reveal that TSG-6 inhibits RANKL-induced osteoclast differentiation/activation from human and murine precursor cells, where elevated dentine erosion by osteoclasts derived from TSG-6-/- mice is consistent with the very severe arthritis seen in these animals. However, the long bones from unchallenged TSG-6-/- mice were found to have higher trabecular mass than controls, suggesting that in the absence of inflammation TSG-6 has a role in bone homeostasis; we have detected expression of the TSG-6 protein in the bone marrow of unchallenged wild type mice. Furthermore, we have observed that TSG-6 can inhibit bone morphogenetic protein-2 (BMP-2)-mediated osteoblast differentiation. Interaction analysis revealed that TSG-6 binds directly to RANKL and to BMP-2 (as well as other osteogenic BMPs but not BMP-3) via composite surfaces involving its Link and CUB modules. Consistent with this, the full-length protein is required for maximal inhibition of osteoblast differentiation and osteoclast activation, although the isolated Link module retains significant activity in the latter case. We hypothesize that TSG-6 has dual roles in bone remodeling; one protective, where it inhibits RANKL-induced bone erosion in inflammatory diseases such as arthritis, and the other homeostatic, where its interactions with BMP-2 and RANKL help to balance mineralization by osteoblasts and bone resorption by osteoclasts
- âŠ